First Symposium on Pediatric Neurotransmitter Diseases Presented by the National Institute of Health Office of Rare Diseases, the National Institute of Neurological Disorders and Stroke and the PND Association. Held May 17th-19th 2002 Symposium Medical & Scientific Organizing Committee Cathrine Ascher R.N. MSN, Schneider Children's Hospital, New Hyde Park, NY Darryl C. De Vivo M.D., Columbia-Presbyterian Medical Center, New York, NY K. Michael Gibson PH.D. FACMG, Oregon Health Sciences University, Portland, OR Andrea Gropman M.D., National Institute of Health, Bethesda, MD Keith Hyland, PH.D, Baylor University Medical Center, Dallas, TX Phillip L. Pearl M.D., Children's National Medical Center, Washington, DC Giovanna Spinella M.D., National Institute of Health, Bethesda, MD Kathryn J. Swoboda M.D., Primary Children's Medical Center, Salt Lake City, UT Presenters Medical & Scientific Organizing Committee Teodoro Bottiglieri PH.D, Baylor University Medical Center, Dallas TX Jayanta Roy Chowdhury M.D., Marion Bessin Liver Research Center, Bronx, NY Blair Ford M.D., Columbia Presbyterian Medical Center, New York, NY Georg F. Hoffmann M.D., University of Heidelberg, Germany Un Jung Kang M.D., The University of Chicago, Il Masaya Segawa M.D., PH.D, Segawa Neurological Clinic for Children, Tokyo, Japan O.C. Snead M.D., Hospital for Sick Children, Toronto, CA Clive Svendsen PH.D., The Waisman Center, Madison, WI Xiaoxi Zhuang PH.D, The University of Chicago, Il PND Board Members/Family Disease Representatives Charlie Cargill - GTP I Disease Representative Stacey Cargill - GTP I Disease Representative Kelly Heger - Aromatic L- Amino Acid Decarboxylase Deficiency Disease Representative Brad Hoffman - VP PND, Succinic Semialdehyde Dehydrogenase Deficiency Disease Representative Carolyn Hoffman - VP. PND, Succinic Semialdehyde Dehyrodgenase Deficiency Disease Representative Liz McKinnon - Sec. PND, Tyrosine Hydroxylase Deficiency Disease Representative Nancy Speller - Pres. PND, Unknown Biogenic Amine Defects Disease Representative John Speller - Tres. PND, Unknown Biogenic Amine Defects Disease Representative Symposium Summary Closing Remarks: Addressing the Issues-Next Steps Symposium Session Summaries Obtain a videotape of the Symposium [Home]  [What are Neurotransmitters]  [What are PND's]  [Disease Information]  [Testing]  [Disease Databases]  [Family and Professional Registry]  [What's New]   [Board of Directors]  [Medical & Scientific Board]  [Literature]  [Helpful Links]  [Our Kids]  [Online Support Group]  [First Symposium on PND'S]